NCT03431714View on ClinicalTrials.gov

Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania

PHASE4CompletedINTERVENTIONAL

Enrollment

333

Participants

Timeline

Start Date

July 14, 2017

Primary Completion Date

December 8, 2017

Study Completion Date

December 8, 2017

Conditions

Uncomplicated Falciparum Malaria

Interventions

DRUG

Artesunate amodiaquine

Drugs were administered under observation of the study nurse for three days

Trial Locations (1)

Unknown

National Institute for Medical Research, Tanga

All Listed Sponsors

collaborator

Muhimbili University of Health and Allied Sciences

OTHER

collaborator

World Health Organization

OTHER

lead

National Institute for Medical Research, Tanzania

OTHER_GOV

NCT03431714 - Efficacy and Safety of ASAQ and PD for the Treatment of Uncomplicated Falciparum Malaria in Mainland Tanzania | Biotech Hunter | Biotech Hunter